From keeping our nation at the cutting edge to employing millions and supporting countless businesses, America's biopharmaceutical companies help drive the economy through a commitment to innovation.
From keeping our nation at the cutting edge to employing millions and supporting countless businesses, America's biopharmaceutical companies are growing the economy through a commitment to innovation.
The American Innovation Engine: Keeping the United States Competitive for Biopharmaceutical Investors
Investment is a key driver of innovation across all industries. However, investment is especially important to the research-intensive biopharmaceutical industry.
The biopharmaceutical industry directly employs nearly 803,000 Americans–but that's only part of the story. In fact, the industry supports over 4.7 million U.S. jobs.
Supporting research and development from America's biopharmaceutical companies means investment in economic growth on a local and national level.
Innovation does not happen in a vacuum. Instead, it requires a rich ecosystem of talent, capital, expertise and logistics to translate theoretical science into life-saving treatments and therapies.
Endometriosis affects an estimated one in 10 women and is associated with debilitating pain symptoms and increased financial burden to patients and the health care system. Dr. Dawn Carlson shares how the biopharmaceutical industry is making an impact on the diagnosis and treatment of a disease that has not seen innovation in decades.
A New Age of Viral Disease Treatment: The Cure Developed by Biopharmaceutical Companies that Saved a Mother of Six
Hepatitis C kills more Americans than any other infectious disease. Carleen was one of those affected. She had five children and was pregnant with her sixth when she was diagnosed with the disease.